{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T20:53:32Z","timestamp":1786136012789,"version":"build-2736575974"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"32","license":[{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8,7]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Childhood leukemia remains a critical global public health challenge, contributing significantly to disability and premature mortality. Despite progress in healthcare, comprehensive estimates of its burden across geographic and sociodemographic strata remain essential for formulating evidence-based interventions. Utilizing data from the Global Burden of Diseases 2021, this cross-sectional study analyzed leukemia incidence, deaths, and disability-adjusted life years (DALYs) among children aged 0 to 14 across 204 countries and territories from 1990 to 2021. Stratified analyses by region, nation, age, sex, leukemia type, and Sociodemographic Index (SDI) were conducted, with estimated annual percentage changes calculated to assess trends. In 2021, childhood leukemia caused 58,785 incident cases (95% uncertainty interval [UI], 43,200\u201373,139), 27,861 deaths, and 2,341,610 DALYs globally, corresponding to an incidence rate of 4.37 per 100,000 (95% UI, 3.51\u20135.46). From 1990 to 2021, global incidence and death rates declined by a total of 0.23% (95% UI, \u22120.44% to \u22120.11%) and 0.52% (95% UI, \u22120.64% to \u22120.35%), respectively. However, the low-SDI region exhibited rising incidence, mortality, and DALY rates. Australasia experienced the largest incidence increase (estimated annual percentage change: 0.67%, 95% confidence interval, 0.23%\u20131.11%). Nationally, San Marino reported the highest incidence (13.79 per 100,000; 95% UI, 8.03\u201321.07), while Tokelau had the highest mortality (7.92 per 100,000; 95% UI, 4.36\u201313.32) and DALY rates (116.39 per 100,000; 95% UI, 86.46\u2013139.97). Despite global reductions in childhood leukemia burden over 3 decades, persistent disparities across SDI subgroups and regions underscore unmet needs in low-resource settings. Precision epidemiology and context-specific strategies are imperative to mitigate inequities and optimize prevention and care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000050068","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T18:02:06Z","timestamp":1786125726000},"page":"e50068","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Global, regional, and national epidemiology of leukemia in children from 1990 to 2021: A cross-sectional study"],"prefix":"10.1097","volume":"105","author":[{"given":"Fuhui","family":"Liu","sequence":"first","affiliation":[{"name":"School of Clinical Medicine, Shandong Second Medical University, Weifang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5036-2870","authenticated-orcid":false,"given":"Wenxu","family":"Niu","sequence":"additional","affiliation":[{"name":"Weifang People\u2019s Hospital, Shandong Second Medical University, Weifang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260807","doi-asserted-by":"crossref","first-page":"e0287917","DOI":"10.1371\/journal.pone.0287917","article-title":"National and subnational burden of leukemia and its risk factors, 1990\u20132019: results from the Global Burden of Disease Study 2019.","volume":"18","author":"Poopak","year":"2023","journal-title":"PLoS One"},{"key":"R2-20260807","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/ajh.26751","article-title":"The international consensus classification of myeloid neoplasms and acute leukemias: myeloproliferative neoplasms.","volume":"98","author":"Thiele","year":"2023","journal-title":"Am J Hematol"},{"key":"R3-20260807","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00428-022-03430-4","article-title":"The international consensus classification of acute myeloid leukemia.","volume":"482","author":"Weinberg","year":"2023","journal-title":"Virchows Arch"},{"key":"R4-20260807","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1038\/s41375-023-01962-5","article-title":"Correction: \u201cThe 5th edition of The World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms\u201d Leukemia. 2022 Jul;36(7):1720\u20131748.","volume":"37","author":"Alaggio","year":"2023","journal-title":"Leukemia"},{"key":"R5-20260807","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0140-6736(18)31041-9","article-title":"Acute myeloid leukaemia.","volume":"392","author":"Short","year":"2018","journal-title":"Lancet"},{"key":"R6-20260807","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0140-6736(12)62187-4","article-title":"Acute lymphoblastic leukaemia.","volume":"381","author":"Inaba","year":"2013","journal-title":"Lancet"},{"key":"R7-20260807","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s11899-017-0380-3","article-title":"New therapeutic strategies in acute lymphocytic leukemia.","volume":"12","author":"Man","year":"2017","journal-title":"Curr Hematol Malig Rep"},{"key":"R8-20260807","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jpeds.2018.07.039","article-title":"Next-generation evaluation and treatment of pediatric acute lymphoblastic leukemia.","volume":"203","author":"Heikamp","year":"2018","journal-title":"J Pediatr"},{"key":"R9-20260807","doi-asserted-by":"crossref","first-page":"2040620719860645","DOI":"10.1177\/2040620719860645","article-title":"Novel therapy in acute myeloid leukemia (AML): moving toward targeted approaches.","volume":"10","author":"Winer","year":"2019","journal-title":"Ther Adv Hematol"},{"key":"R10-20260807","doi-asserted-by":"crossref","first-page":"106337","DOI":"10.1016\/j.leukres.2020.106337","article-title":"Novel therapeutic approaches in chronic myeloid leukemia.","volume":"91","author":"\u00d6zg\u00fcr Yurtta\u015f","year":"2020","journal-title":"Leuk Res"},{"key":"R11-20260807","doi-asserted-by":"crossref","first-page":"e7150","DOI":"10.1002\/cam4.7150","article-title":"Global, regional, and national burdens of leukemia from 1990 to 2019: a systematic analysis of the global burden of disease in 2019 based on the APC model.","volume":"13","author":"Qu","year":"2024","journal-title":"Cancer Med"},{"key":"R12-20260807","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1200\/JCO.21.01693","article-title":"Phase II trial of inotuzumab ozogamicin in children and adolescents with relapsed or refractory B-cell acute lymphoblastic leukemia: Children\u2019s Oncology Group protocol AALL1621.","volume":"40","author":"O\u2019Brien","year":"2022","journal-title":"J Clin Oncol"},{"key":"R13-20260807","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1200\/JCO.21.02678","article-title":"Children\u2019s Oncology Group trial AALL1231: a phase III clinical trial testing bortezomib in newly diagnosed T-cell acute lymphoblastic leukemia and lymphoma.","volume":"40","author":"Teachey","year":"2022","journal-title":"J Clin Oncol"},{"key":"R14-20260807","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1056\/NEJMoa1709866","article-title":"Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia.","volume":"378","author":"Maude","year":"2018","journal-title":"N Engl J Med"},{"key":"R15-20260807","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","article-title":"Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021.","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"R16-20260807","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/S0140-6736(24)00367-2","article-title":"Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021.","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"R17-20260807","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(14)61682-2","article-title":"Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013.","volume":"385","year":"2015","journal-title":"Lancet"},{"key":"R18-20260807","doi-asserted-by":"crossref","first-page":"e279","DOI":"10.1212\/WNL.0000000000013115","article-title":"Global, regional, and national burden of ischemic stroke, 1990\u20132019.","volume":"98","author":"Ding","year":"2022","journal-title":"Neurology"},{"key":"R19-20260807","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.0081-1750.2004.00148.x","article-title":"2. A methodological comparison of age-period-cohort models: the intrinsic estimator and conventional generalized linear models.","volume":"34","author":"Yang","year":"2004","journal-title":"Sociol Methodol"},{"key":"R20-20260807","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1186\/s12887-025-05847-7","article-title":"Global, regional, and national burden of childhood leukemia from 1990 to 2021.","volume":"25","author":"Liu","year":"2025","journal-title":"BMC Pediatr"},{"key":"R21-20260807","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1001\/jama.290.15.2001","article-title":"Results of therapy for acute lymphoblastic leukemia in black and white children.","volume":"290","author":"Pui","year":"2003","journal-title":"JAMA"},{"key":"R22-20260807","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/jamaoncol.2019.2996","article-title":"Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the Global Burden of Disease Study.","volume":"5","author":"Fitzmaurice","year":"2019","journal-title":"JAMA Oncol"},{"key":"R23-20260807","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/oxfordjournals.epirev.a036153","article-title":"Epidemiology of childhood leukemia, with a focus on infants.","volume":"16","author":"Ross","year":"1994","journal-title":"Epidemiol Rev"},{"key":"R24-20260807","first-page":"909","article-title":"Parental occupational exposures and risk of childhood cancer.","volume":"106","author":"Colt","year":"1998","journal-title":"Environ Health Perspect"},{"key":"R25-20260807","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/aje\/kww018","article-title":"Parental tobacco smoking and acute myeloid leukemia: the Childhood Leukemia International Consortium.","volume":"184","author":"Metayer","year":"2016","journal-title":"Am J Epidemiol"},{"key":"R26-20260807","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1093\/ajcn\/nqac283","article-title":"Periconceptional folate intake influences DNA methylation at birth based on dietary source in an analysis of pediatric acute lymphoblastic leukemia cases and controls.","volume":"116","author":"Nickels","year":"2022","journal-title":"Am J Clin Nutr"},{"key":"R27-20260807","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1182\/blood-2014-02-554204","article-title":"A distinct glucose metabolism signature of acute myeloid leukemia with prognostic value.","volume":"124","author":"Chen","year":"2014","journal-title":"Blood"},{"key":"R28-20260807","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1021\/pr400403p","article-title":"Rapid diagnosis and prognosis of de novo acute myeloid leukemia by serum metabonomic analysis.","volume":"12","author":"Wang","year":"2013","journal-title":"J Proteome Res"},{"key":"R29-20260807","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/ajh.26822","article-title":"Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and management.","volume":"98","author":"Shimony","year":"2023","journal-title":"Am J Hematol"},{"key":"R30-20260807","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s00383-021-04939-6","article-title":"A critical threshold for global pediatric surgical workforce density.","volume":"37","author":"Bouchard","year":"2021","journal-title":"Pediatr Surg Int"},{"key":"R31-20260807","first-page":"130","article-title":"The treatment of acute myeloid leukemia in Brazil: progress and obstacles.","volume":"80","author":"Pulcheri","year":"1995","journal-title":"Haematologica"},{"key":"R32-20260807","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/MPH.0000000000000285","article-title":"Pediatric medical care system in China has significantly reduced abandonment of acute lymphoblastic leukemia treatment.","volume":"37","author":"Zhou","year":"2015","journal-title":"J Pediatr Hematol Oncol"},{"key":"R33-20260807","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s12529-016-9560-0","article-title":"Care utilization with China\u2019s new rural cooperative medical scheme: updated evidence from the China Health and Retirement Longitudinal Study 2011\u20132012.","volume":"23","author":"Zhang","year":"2016","journal-title":"Int J Behav Med"},{"key":"R34-20260807","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/ped4.12279","article-title":"Pediatric cancer surveillance in China: a hospital-based introduction.","volume":"5","author":"Li","year":"2021","journal-title":"Pediatr Investig"},{"key":"R35-20260807","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S0140-6736(22)01541-0","article-title":"Socioeconomic inequalities in cancer incidence and access to health services among children and adolescents in China: a cross-sectional study.","volume":"400","author":"Ni","year":"2022","journal-title":"Lancet"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050068","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T20:02:44Z","timestamp":1786132964000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":35,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000050068","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,7]]},"assertion":[{"value":"2025-11-04","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-21","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}